All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drpompaofficial on TikTok · 45s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drpompaofficial's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Peptides you want to know more about peptides look at my stash. I'm really into peptides
  2. 0:04But look not all peptides which ones are good which ones are bad
  3. 0:07What do I do about these peptides? Everyone's telling me about how do I order them?
  4. 0:11There are some peptides that are dangerous shouldn't touch them and there's some peptides that are safe depending on where you get them
  5. 0:16I did a podcast a solo where I just brought you the information
  6. 0:20matter of fact just put in POD pod and I'll send you the link because I went through all the ones that you just saw right there
  7. 0:27All the ones that I like different ones from my wife than myself obviously
  8. 0:31But the ones that I think are absolutely worth the time and effort
  9. 0:34But most importantly I think because there's so many good ones bad ones risks, etc
  10. 0:39I think this podcast is very essential put in POD send you the link watch it good info

@drpompaofficial's peptide recommendations, fact-checked

drpompaofficial

TikTok creator

13.4K viewsWatch on TikTok →

Quick answer

This video does not make specific clinical claims but promotes peptide use broadly while directing viewers to an external podcast for substantive information. Many peptides referenced visually in Dr. Pompa's collection, including BPC-157 and CJC-1295, are currently restricted from compounding by the FDA under 503A and 503B pharmacy regulations updated in 2023 and 2024. Anyone considering peptide therapy should consult a licensed physician rather than self-directing based on social media recommendations, given the evolving regulatory status and limited Phase III human trial data for most compounds in this category.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion
Start provider reviewBrowse video library

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drpompaofficial's peptide recommendations, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

ReviewBPC-157 evidence2025

Multifunctionality and Possible Medical Application of the BPC 157 Peptide

Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.

PubMed

ReviewBPC-157 evidence2019

Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.

PubMed

ReviewGrowth-hormone peptide evidence1998

Ipamorelin, the first selective growth hormone secretagogue

Background source for ipamorelin selectivity and GH-secretagogue mechanism.

PubMed

ReviewGrowth-hormone peptide evidence2001

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation

Preclinical context that should not be overstated as consumer clinical evidence.

PubMed

Provider decision path

Use local research to choose a safer review path

Direct answer

@drpompaofficial's peptide recommendations, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Start the provider review

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Helpful context before the funnel

Review method

See how FormBlends checks viral health claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drpompaofficial's peptide recommendations, fact-checked" from drpompaofficial. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video does not make specific clinical claims but promotes peptide use broadly while directing viewers to an external podcast for substantive information.

The reason this review is not generic is the source wording and the canonical claim label "peptides the only peptides i recommend." In this clip, the useful excerpt is: "Peptides you want to know more about peptides look at my stash." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

MK-677, often grouped with peptides in wellness content, is actually a small molecule ghrelin mimetic, not a peptide, and has no FDA approval for any human indication.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video does not make specific clinical claims but promotes peptide use broadly while directing viewers to an external podcast for substantive information.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video does not make specific clinical claims but promotes peptide use broadly while directing viewers to an external podcast for substantive information. Many peptides referenced visually in Dr. Pompa's collection, including BPC-157 and CJC-1295, are currently restricted from compounding by the FDA under 503A and 503B pharmacy regulations updated in 2023 and 2024. Anyone considering peptide therapy should consult a licensed physician rather than self-directing based on social media recommendations, given the evolving regulatory status and limited Phase III human trial data for most compounds in this category.
  • As of 2023-2024, the FDA restricted compounding of BPC-157, CJC-1295, and ipamorelin, meaning these cannot be legally compounded at US pharmacies for patient use under current rules.
  • MK-677, often grouped with peptides in wellness content, is actually a small molecule ghrelin mimetic, not a peptide, and has no FDA approval for any human indication.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • As of 2023-2024, the FDA restricted compounding of BPC-157, CJC-1295, and ipamorelin, meaning these cannot be legally compounded at US pharmacies for patient use under current rules.
  • MK-677, often grouped with peptides in wellness content, is actually a small molecule ghrelin mimetic, not a peptide, and has no FDA approval for any human indication.
  • A 2021 review by Lau and Dunn in British Journal of Clinical Pharmacology found that most research peptides used in the optimization space have limited or no completed Phase III human clinical trial data.
  • Source quality does affect purity and contamination risk, but a pure, well-sourced unapproved compound is still an unapproved compound with uncharacterized long-term safety in humans.
  • GHK-Cu used topically in cosmetic formulations has a different and more established regulatory status than injectable peptides and should not be conflated with injectable research compounds.
  • Cohen et al. (2016, JAMA Internal Medicine) found significant label inaccuracy in performance enhancement products, confirming that sourcing concerns are legitimate but not sufficient to resolve safety questions.
  • No peer-reviewed clinical guidelines from organizations such as the Endocrine Society or AACE currently endorse peptide stacking protocols of the kind promoted in biohacking content.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drpompaofficial actually say?

Not much, honestly. The video is essentially an advertisement for a podcast episode. Dr. Pompa gestures at his peptide collection, says "there are some peptides that are dangerous, shouldn't touch them" and some that are safe "depending on where you get them," then asks viewers to DM him the word "POD" for a link. No specific peptides are named, no mechanisms are explained, and no evidence is cited. This is a teaser, not a health claim, which makes it tricky to fact-check directly. But the framing itself carries implicit claims worth examining: that peptide safety is a binary good/bad question, and that source quality determines safety. Those assumptions deserve scrutiny.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

drpompaofficial · TikTok creator

13.4K views on this video

The ONLY Peptides I Recommend 💉✅

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about as of 2023-2024, the fda restricted compounding of bpc-157, cjc-1295,?

As of 2023-2024, the FDA restricted compounding of BPC-157, CJC-1295, and ipamorelin, meaning these cannot be legally compounded at US pharmacies for patient use under current rules.

What does the video say about mk-677, often grouped with peptides in wellness content,?

MK-677, often grouped with peptides in wellness content, is actually a small molecule ghrelin mimetic, not a peptide, and has no FDA approval for any human indication.

What does the video say about a 2021 review by lau?

A 2021 review by Lau and Dunn in British Journal of Clinical Pharmacology found that most research peptides used in the optimization space have limited or no completed Phase III human clinical trial data.

What does the video say about source quality does affect purity?

Source quality does affect purity and contamination risk, but a pure, well-sourced unapproved compound is still an unapproved compound with uncharacterized long-term safety in humans.

What does the video say about ghk-cu used topically in cosmetic formulations has a different?

GHK-Cu used topically in cosmetic formulations has a different and more established regulatory status than injectable peptides and should not be conflated with injectable research compounds.

What does the video say about cohen et al. (2016, jama internal medicine) found significant label?

Cohen et al. (2016, JAMA Internal Medicine) found significant label inaccuracy in performance enhancement products, confirming that sourcing concerns are legitimate but not sufficient to resolve safety questions.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by drpompaofficial, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.